Eliminating cancer cell repopulation may be the key to curing cancer

A new research perspective was published in Oncoscience (Volume 10) on June 1, 2023, entitled, "Cancer cell repopulation after therapy: which is the mechanism?"

The past two decades have brought great progress in the treatment of cancer as patients with the disease live longer having access to better diagnosis and therapeutic approaches. However, the disease remains incurable. One of the reasons for the high resilience of this disease is that cancer cells hide and escape from therapies thus leading to cancer recurrence. The process whereby cells escape therapy is referred to as cancer cell repopulation.

Cancer cell repopulation after therapy is a phenomenon that leads to therapeutic failure with the consequent relapse of the disease. The process is understudied and mechanisms need to be uncovered. In this new perspective, researchers Rewati Prakash and Carlos M. Telleria from McGill University and McGill University Health Centre discuss the issue of cancer cell repopulation after chemo- and radio-therapies.

The researchers compiled evidence alleging that the repopulation of cancer cells can be originated from either cancer stem cells resistant to therapy, cancer cells that in response to therapy become polyploid and thereafter germinate into near-diploid rapid proliferating cells, and/or cells that respond to treatment undergoing senescence as a transient mechanism to survive, followed by the reinitiation of the cell cycle.

"Perhaps the better approach to eliminate cancer cell repopulation is a combination treatment involving first chemoradiation-induced transitory senescence, followed by senolytic therapies as recently discussed by Wang and colleagues."

Source:
Journal reference:

Prakash, R & Telleria, C. M., (2023) Cancer Cell Repopulation After Therapy: Which is the Mechanism?. Oncoscience. doi.org/10.18632/oncoscience.577.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients